Nanobiotix is trading 5.1% down at $39.54, with no fresh company-specific announcement or clearly disclosed catalyst for September 3, 2026 identified.
- Recent coverage points to the previously completed May follow-on offering, not a new event today.
- The decline is occurring despite stronger broader markets and biotechnology-sector gains, suggesting profit-taking or stock-specific trading pressure rather than a sector-wide selloff.
- Confidence is low because no direct cause has been confirmed.